iosr-JDMS   Volume-17 ~ Issue-9 ~ September-2018

Abstract: BACKGROUND : Tuberculosis (TB) is a communicable disease requiring prolonged treatment. Poor adherence to a prescribed treatment increases the risk of morbidity, mortality, and spread of disease in the community Further poor adherence to treatment leads to emergence of multi-drug-resistant bacilli, so ensuring compliance is of utmost importance to control TB and halt the MDR TB epidemic at its beginning. So there is continuing need to sustain and further intensify the actions being undertaken to reduce default. AIMS AND OBJECTIVES: To study various factors associated with non compliance to DOTS. MATERIAL AND METHODS......

Key words: DOTS, tuberculosis, non-compliance, compliance, defaulter

[1]. Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, et al. Reasons for non compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, South India. Indian J Tuberc. 2007;54:130–5.[PubMed]

[2]. TB - A Global Emergence. Geneva: World Health Organization; 1994. World Health Organization. WHO/TB/94.177.

[3]. Dhuria M, Sharma N, Ingle GK. Impact of tuberculosis on the quality of life. Indian J Community Med. 2008;33:58–9. [PMC free article] [PubMed]

[4]. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bhavan, New Delhi. TB India 2014. Revised National TB Control Programme. Annual Status Report. Reach the Unreached. Find, Treat, Cure TB, Save Lives.2014. [Last accessed on 2014 Dec 26]. pp. 7–59. Available from: http://www.tbcindia.nic.in .

[5]. Chhaya Mittal, SC Gupta. Noncompliance to DOTS: How it can be Decreased. Indian J Community Med. 2011 Jan-Mar; 36(1): 27–30.

Abstract: BACKGROUND: Post-operative hypocalcemia is a common event after extensive thyroid surgery. It can be transient or permanent. It can symptomatic or asymptomatic.symptomatic patients can present with mild or severe symptoms accordinlg to which correction of serum calcium levels may be required. AIMS: Our study is to evaluate the incidence of hypocalcemia after total thyroidectomy,to analyse the severity of presentation and to study about various modalities of treatment available. METHODS: The study was..............

Key words:Hypocalcemia,Parathyroid,Thyroid,vitamin D,

[1]. Hypocalcemia and hypoparathyroidism after total thyroidectomy: a clinical biological study and surgical considerations.Sturniolo G, Lo Schiavo MG, Tonante A, D'Alia C, Bonanno L.Int J Surg Investig. 2000; 2(2):99-105.

[2]. Hypocalcemia following total thyroidectomy: early factors predicting long-term outcome. Pisanu A, Piu S, Cois A, Uccheddu A.G Chir. 2005 Apr; 26(4):131-4.

[3]. [Parathyroid hypofunction after total thyroidectomy for differentiated thyroid carcinoma--perspectives after long term observation and treatment]. Godlewska P, Kaniewski M, Stachlewska-Nasfeter E, Bisz D, Łyczek J.Wiad Lek. 2001; 54 Suppl 1:398-404.

[4]. Predictors of postoperative hypocalcemia occurring after a total thyroidectomy: results of prospective multicenter study. Eismontas V, Slepavicius A, Janusonis V, Zeromskas P, Beisa V, Strupas K, Dambrauskas Z, Gulbinas A, Martinkenas A.BMC Surg. 2018 Aug 9; 18(1):55. Epub 2018 Aug 9............

Abstract: The aim was to study the distribution of morphological pattern of Benign and Malignant ovarian neoplasm in different age groups in a tertiary care hospital in Ahmedabad and to provide specific diagnosis based on histomorphology.The Data pertaining to sample of received for histopathological evaluation at the laboratory of a tertiary care hospital in Ahmedabad. Over a priod of 2 year( from June - 2016 to June 2018) all the relavant data of patients analysed from hospital record file. A total of 105 cases with ovarian lesion were seen from the year (june-..........

Keyword- corpus luteal cyst, mucinous cyst adenoma, neoplasm

[1]. Sikdar K, Kumar P, Roychowdhary NN. A study of ovarian malignancy: A review of 149 cases. J Obstetric Gynaecology India. 1981;30:478–80.
[2]. Zaman S; Majid S, Hussain M, Chughtai O, Mahboob J, Chughtai S. A retrospective study of ovarian tumours and tumour like lesion. J Ayub Med Coll Abbottabad 2010;22:104-8
[3]. Kayastha S. Study of ovarian tumours in Nepal Medical College Teaching Hospital. Nepal Med Coll J 2009;11:200-2.
[4]. Cho KR, Shih Iem. Ovarian cancer. Annu Rev Pathol 2009;4:287-313.
[5]. Stany MP, Hamilton CA. Benign disorders of the Ovary. Obstet Gynecol Clin North Am 2008;35:271-84..

Abstract: Biopsy is a valuable aid in diagnosis of diseases which consists of obtaining a specimen of living tissue in order to study its structure, both macro and microscopically. This procedure makes it possible to confirm or deny a diagnosis, as well as to determine the nature and characteristics of the lesion to establish a final diagnosis. As with any disease process in dentistry and medicine, prevention is the best form of therapy and early diagnosis and treatment is the best way of managing pathologic entities. The present paper provides an update on the different biopsy techniques and their indications.........

Key words: Biopsy, oral biopsy, surgical considerations in biopsy, oral diagnosis.

[1]. Sinaniotis CA and Sinaniotis AC. Community-acquired pneumonia in children. Curr Opin Pulm Med 2005; 11: 218-25
[2]. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Michael Harris, Julia Clark, Nicky Coote, Penny Fletcher, Anthony Harnden, Michael McKean, Anne Thomson, On behalf of the British Thoracic Society Standards of Care Committee. Thorax- An International Journal of Respiratory Medicine, October 2011, Volume 66, Supplement 2.
[3]. Le Moullec, J.M., Jullienne, A., Chenais, J., Lasmoles, F., Guliana, J.M., Milhaud, G., and Moukhtar, M.S. (1984) The complete sequence of human procalcitonin. FEBS Lett. 167, 93–97.
[4]. Assicot, M., Gendrel, D., Carsin, H., Raymond, J., Guilbaud, J., and Bohuon, C. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341, 515–518.
[5]. Schneider, H.G. and Lam, Q.T. (2007) Procalcitonin for the clinical laboratory: a review. Pathology 39, 383–390.